NCT04703699 Myval Global Study of Myval™ THV Series Implanted in Patients With Native Severe Aortic Valve Stenosis.
| NCT ID | NCT04703699 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Meril Life Sciences Pvt. Ltd. |
| Condition | Aortic Valve Stenosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2020-08-07 |
| Primary Completion | 2024-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2020-08-07 with a primary completion date of 2024-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A retrospective, multinational, multicentre, observational study in patients presenting with native severe aortic valve stenosis and treated with Myval™ Transcatheter Heart Valve Series in real-world setting.
Eligibility Criteria
Inclusion Criteria: * All patients of this study must have received Myval™ THV series for treatment of native severe aortic stenosis and completed a minimum of 30-day follow-up. Exclusion Criteria: * No
Contact & Investigator
Ashok Thakkar, Ph.D.
STUDY CHAIR
Head - Clinical Research and Medical Writing
Frequently Asked Questions
Who can join the NCT04703699 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Aortic Valve Stenosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04703699 currently recruiting?
Yes, NCT04703699 is actively recruiting participants. Contact the research team at Ashok.Thakkar@merillife.com for enrollment information.
Where is the NCT04703699 trial being conducted?
This trial is being conducted at Tallinn, Estonia, Milan, Italy, Breda, Netherlands, Gdansk, Poland and 4 additional locations.
Who is sponsoring the NCT04703699 clinical trial?
NCT04703699 is sponsored by Meril Life Sciences Pvt. Ltd.. The principal investigator is Ashok Thakkar, Ph.D. at Head - Clinical Research and Medical Writing. The trial plans to enroll 200 participants.